We are a venture capital partnership investing in
Good Health, for Everyone.
Our partner companies are delivering
medical financial aid
robotic testing systems for pandemic response
care for depression
clinical trials into the digital era
, and more ↓
Synthetic biomarkers for early detection of cancers.
Co-investors: Andreesen Horowitz, Sands Capital, Perceptive Advisors, Khosla Ventures
Delivering accesible, digital-first care for depression and anxiety.
Co-investors: Bullpen Capital, Slow Ventures
Making laboratory automation available to biologists everywhere.
Co-investors: Sands Capital, Khosla Ventures, Lehrer Hippeau
Educating clinicians and caregivers all over the world.
Co-investors: Felicis Ventures, Greycroft
Using artifical intelligence to get patients to the right care at the right time.
Co-investors: F Prime, Optum Ventures, CIGNA, Humana
Creating a complete precision health testing platform.
Co-investors: General Catalyst, Pear VC
Building a best-in-class orthodontics platform.
Co-investors: Canaan Partners, Lehrer Hippeau
Creating the world's first long-lasting, reversible contraceptive for men.
Co-investors: Founders Fund
Developing clinically validated games to treat hyperactivity disorders.
Co-investors: Slow Ventures, Founder Collective
Making medical transportation simple.
Co-investors: NEA, Fresenius, FCA Venture Partners
Providing collaborative mental heatlh care to those that need it most.
Co-investors: Town Hall Ventures, Healthy Ventures
Making medical financial aid available to vulnerable patients.
Co-investors: Global Founders Capital
Helping smokers quit with cleaner nicotine alternatives.
Co-investors: Greycroft, RRE
Bringing telemedicine into rural skilled nursing facilities.
Co-investors: Bloomberg Beta
Eliminating infections from catheter based treatments.
Co-investors: Confidential Strategic Investors
Treating blocked arteries with novel shockwaves.
Co-investors: Fidelity Management
Accelerating clinical trials with digital biomarkers.
Co-investors: Spring Mountain, Waterline
Ensuring hospitals can always respond effectively to patient demand.
Co-investors: Coelius Capital, High Sage Ventures
Applying synthetic biology to create first-in-class vaccines.
Co-investors: Morningside Ventures
Growing autologous bone tissue.
Co-investors: Alexandria Venture Investments
Treating brain disorders with novel thin film electrodes.
Co-investors: Mayo Clinic
Creating superelastic implants to treat benign prostatic hyperplasia.
Co-investors: F Prime
Applying behavioral economics to improve adherence to care plans.
Co-investors: AXA Venture Partners, Boehringer Ingelheim
Crafting clinically effective and delicious food to treat GI conditions.
Co-investors: Mount Sinai Health System
Providing digital solutions for home health care workers.
Co-investors: Crosslink Capital, Bowery Capital
Developing glucose-responsive, once-a-day insulin.
Co-investors: PBM Capital
Inventing novel therapeutics to address urological conditions.
Co-investors: Romulus Capital
Enabling real-time, visual and quantitative blood flow monitoring.
Co-investors: Grey Sky Venture Partners
Making interventional procedures safer with a novel needle guidance system.
Co-investors: Maryland Venture Fund
Precisely measuring emotional responses with neurotechnology.
Co-investors: Thiel Capital
Leveraging novel biomaterials to extend drugs' therapeutic potential.
Co-investors: Lumira Capital
Delivering physical therapy to patients' homes.
Bringing pioneering oncology assets into the clinic.
Co-investors: Boxcar Partners
Protecting against indoor air pollution and air-based pathogens.
Co-investors: Global Asset Capital
Creating a drug discovery engine for previously undrugable genetic targets.
Bringing lab testing to point-of-care.
Co-investors: Inovia Capital
Out of gallery